Nucleoporin107 mediates female sexual differentiation via Dsx

  1. Tikva Shore
  2. Tgst Levi
  3. Rachel Kalifa
  4. Amatzia Dreifuss
  5. Dina Rekler
  6. Ariella Weinberg-Shukron
  7. Yuval Nevo
  8. Tzofia Bialistoky
  9. Victoria Moyal
  10. Merav Yaffa Gold
  11. Shira Leebhoff
  12. David Zangen
  13. Girish Deshpande  Is a corresponding author
  14. Offer Gerlitz  Is a corresponding author
  1. The Hebrew University, Israel
  2. Hebrew University Hadassah Medical School, Israel
  3. The Hadassah Hebrew University Medical Center, Israel
  4. Hadassah Hebrew University Medical Center, Israel
  5. Princeton University, United States

Abstract

We recently identified a missense mutation in Nucleoporin107 (Nup107; D447N) underlying XX-ovarian-dysgenesis, a rare disorder characterized by underdeveloped and dysfunctional ovaries. Modeling of the human mutation in Drosophila or specific knockdown of Nup107 in the gonadal soma resulted in ovarian-dysgenesis-like phenotypes. Transcriptomic analysis identified the somatic sex-determination gene doublesex (dsx) as a target of Nup107. Establishing Dsx as a primary relevant target of Nup107, either loss or gain of Dsx in the gonadal soma is sufficient to mimic or rescue the phenotypes induced by Nup107 loss. Importantly, the aberrant phenotypes induced by compromising either Nup107 or dsx are reminiscent of BMP signaling hyperactivation. Remarkably, in this context, the metalloprotease AdamTS-A, a transcriptional target of both Dsx and Nup107, is necessary for the calibration of BMP signaling. As modulation of BMP signaling is a conserved critical determinant of soma-germline interaction, the sex and tissue specific deployment of Dsx-F by Nup107 seems crucial for the maintenance of the homeostatic balance between the germ cells and somatic gonadal cells.

Data availability

All raw RNA-seq data, as well as software versions and parameters, have been deposited in NCBI's Gene Expression Omnibus and are accessible through GEO Series accession number GSE141094

The following data sets were generated

Article and author information

Author details

  1. Tikva Shore

    Department of Developmental Biology and Cancer Research, The Hebrew University, Jerusalem, Israel
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-7140-0226
  2. Tgst Levi

    Department of Developmental Biology and Cancer Research, The Hebrew University, Jerusalem, Israel
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-9221-1873
  3. Rachel Kalifa

    Department of Developmental Biology and Cancer Research, The Hebrew University, Jerusalem, Israel
    Competing interests
    The authors declare that no competing interests exist.
  4. Amatzia Dreifuss

    Department of Developmental Biology and Cancer Research, The Hebrew University, Jerusalem, Israel
    Competing interests
    The authors declare that no competing interests exist.
  5. Dina Rekler

    Department of Developmental Biology and Cancer Research, The Hebrew University, Jerusalem, Israel
    Competing interests
    The authors declare that no competing interests exist.
  6. Ariella Weinberg-Shukron

    Medical Genetics Institute, Hebrew University Hadassah Medical School, Jerusalem, Israel
    Competing interests
    The authors declare that no competing interests exist.
  7. Yuval Nevo

    Bioinformatics Unit of the I-CORE Computation Center, The Hadassah Hebrew University Medical Center, Jerusalem, Israel
    Competing interests
    The authors declare that no competing interests exist.
  8. Tzofia Bialistoky

    Department of Developmental Biology and Cancer Research, The Hebrew University, Jerusalem, Israel
    Competing interests
    The authors declare that no competing interests exist.
  9. Victoria Moyal

    Department of Developmental Biology and Cancer Research, The Hebrew University, Jerusalem, Israel
    Competing interests
    The authors declare that no competing interests exist.
  10. Merav Yaffa Gold

    Department of Developmental Biology and Cancer Research, The Hebrew University, Jerusalem, Israel
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-9978-2262
  11. Shira Leebhoff

    Department of Developmental Biology and Cancer Research, The Hebrew University, Jerusalem, Israel
    Competing interests
    The authors declare that no competing interests exist.
  12. David Zangen

    Division of Pediatric Endocrinology, Hadassah Hebrew University Medical Center, Jerusalem, Israel
    Competing interests
    The authors declare that no competing interests exist.
  13. Girish Deshpande

    Department of Molecular Biology, Princeton University, Princeton, United States
    For correspondence
    gdeshpande@princeton.edu
    Competing interests
    The authors declare that no competing interests exist.
  14. Offer Gerlitz

    Department of Developmental Biology and Cancer Research, The Hebrew University, Jerusalem, Israel
    For correspondence
    offerg@ekmd.huji.ac.il
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-1574-2088

Funding

Israel Science Foundation (1788/15)

  • David Zangen
  • Offer Gerlitz

Israel Science Foundation (1814/19-)

  • David Zangen
  • Offer Gerlitz

National Institute of Health (093913)

  • Girish Deshpande

Ministry of Science and Technology

  • Tgst Levi

Ministry of Aliyah and Integration

  • Tgst Levi

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Copyright

© 2022, Shore et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 1,157
    views
  • 143
    downloads
  • 7
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Tikva Shore
  2. Tgst Levi
  3. Rachel Kalifa
  4. Amatzia Dreifuss
  5. Dina Rekler
  6. Ariella Weinberg-Shukron
  7. Yuval Nevo
  8. Tzofia Bialistoky
  9. Victoria Moyal
  10. Merav Yaffa Gold
  11. Shira Leebhoff
  12. David Zangen
  13. Girish Deshpande
  14. Offer Gerlitz
(2022)
Nucleoporin107 mediates female sexual differentiation via Dsx
eLife 11:e72632.
https://doi.org/10.7554/eLife.72632

Share this article

https://doi.org/10.7554/eLife.72632

Further reading

    1. Cancer Biology
    2. Developmental Biology
    Sara Jaber, Eliana Eldawra ... Franck Toledo
    Research Article

    Missense ‘hotspot’ mutations localized in six p53 codons account for 20% of TP53 mutations in human cancers. Hotspot p53 mutants have lost the tumor suppressive functions of the wildtype protein, but whether and how they may gain additional functions promoting tumorigenesis remain controversial. Here, we generated Trp53Y217C, a mouse model of the human hotspot mutant TP53Y220C. DNA damage responses were lost in Trp53Y217C/Y217C (Trp53YC/YC) cells, and Trp53YC/YC fibroblasts exhibited increased chromosome instability compared to Trp53-/- cells. Furthermore, Trp53YC/YC male mice died earlier than Trp53-/- males, with more aggressive thymic lymphomas. This correlated with an increased expression of inflammation-related genes in Trp53YC/YC thymic cells compared to Trp53-/- cells. Surprisingly, we recovered only one Trp53YC/YC female for 22 Trp53YC/YC males at weaning, a skewed distribution explained by a high frequency of Trp53YC/YC female embryos with exencephaly and the death of most Trp53YC/YC female neonates. Strikingly, however, when we treated pregnant females with the anti-inflammatory drug supformin (LCC-12), we observed a fivefold increase in the proportion of viable Trp53YC/YC weaned females in their progeny. Together, these data suggest that the p53Y217C mutation not only abrogates wildtype p53 functions but also promotes inflammation, with oncogenic effects in males and teratogenic effects in females.

    1. Developmental Biology
    Mengjie Li, Aiguo Tian, Jin Jiang
    Research Advance

    Stem cell self-renewal often relies on asymmetric fate determination governed by niche signals and/or cell-intrinsic factors but how these regulatory mechanisms cooperate to promote asymmetric fate decision remains poorly understood. In adult Drosophila midgut, asymmetric Notch (N) signaling inhibits intestinal stem cell (ISC) self-renewal by promoting ISC differentiation into enteroblast (EB). We have previously shown that epithelium-derived Bone Morphogenetic Protein (BMP) promotes ISC self-renewal by antagonizing N pathway activity (Tian and Jiang, 2014). Here, we show that loss of BMP signaling results in ectopic N pathway activity even when the N ligand Delta (Dl) is depleted, and that the N inhibitor Numb acts in parallel with BMP signaling to ensure a robust ISC self-renewal program. Although Numb is asymmetrically segregated in about 80% of dividing ISCs, its activity is largely dispensable for ISC fate determination under normal homeostasis. However, Numb becomes crucial for ISC self-renewal when BMP signaling is compromised. Whereas neither Mad RNA interference nor its hypomorphic mutation led to ISC loss, inactivation of Numb in these backgrounds resulted in stem cell loss due to precocious ISC-to-EB differentiation. Furthermore, we find that numb mutations resulted in stem cell loss during midgut regeneration in response to epithelial damage that causes fluctuation in BMP pathway activity, suggesting that the asymmetrical segregation of Numb into the future ISC may provide a fail-save mechanism for ISC self-renewal by offsetting BMP pathway fluctuation, which is important for ISC maintenance in regenerative guts.